Rocket Pharmaceuticals, Inc.

    Jurisdiction
    United States
    LEI
    549300R7VV82YUIN4Y93
    ISIN
    US77313F1066 (RCKT)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 49 / 100
    Even with peer group:
    49 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    1 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€229.77M
    EBIT margin
    0.0%
    Net income
    -€220.88M
    Net margin
    0.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €31.92M +∞% -€143.60M -35.0%
    €32.34M +1.3% -€166.02M +15.6%
    €78.40M +142.4% -€141.64M -14.7%

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Bjork Elisabeth N/A +10K $3.41 +$34.10K
    Militello John See Remarks -1.1K $3.04 -$3.22K
    Schwartz Jonathan David See Remarks -2.5K $3.04 -$7.55K
    Wilson Martin General Counsel -1.6K $3.04 -$4.84K
    Militello John See Remarks -7K $3.02 -$21.27K

    Earnings Calls

    Latest earnings call: August 9, 2021

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 338K $2.26M +120K Buy

    Add to watchlist

    Notifications